A recent webinar sponsored by Formlabs underscored the value of 3D printing from a clinical perspective and offered insight on how commercial and regulatory players are thinking about this space.
Formlabs is sponsoring a webinar exploring 3D printing from clinical, commercial, and regulatory perspectives.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Our latest eBook offers examples of how some of the players in healthcare are thinking about AI, seeking to apply it across care coordination, drug development and early detection of disease and how to address some of the challenges the technology poses for adoption and implementation.
The company just announced strategic alliances with Novartis, Otsuka, Pfizer and Sanofi to develop new clinical research programs utilizing the Project Baseline platform across therapeutic areas ranging from cardiovascular disease to oncology to mental health.
The issue of conflicts of interest has become more pressing in recent years as drug prices soar and healthcare companies reach out to the academic and policy community for advice — often with generous payments attached, ethics experts say.
Verily Life Sciences is partnering with Stanford Medicine and the Duke University School of Medicine to study 10,000 volunteers over four years as part of a new initiative dubbed Project Baseline.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Newly appointed Talkspace advisor Dr. Andrew Sekel is impressed with the progress of text-based health and looks forward to the upcoming findings of efficacy out of Columbia University and Duke University.
The verdict is still out about Dr. Robert Califf. Does he have the right intentions in order to ethically lead the FDA?
A new study shows that younger people may have older biological ages suggesting that studying young people may help in finding cures for old age-related medical conditions.
Cigna and Duke Connected Care have teamed up to form an ACO-like relationship that aims to improve population health of some 10,000 individuals in North Carolina covered by Cigna. The private market has been adopting its own versions of the Medicare-run program, looking to achieve the so-called triple aim of reduced cost, improved care and […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Growing contracting human muscles that responds to stimuli like real tissue sounds more like science fiction than modern science. But it has officially been done, and this could mean a whole new world for testing pharmaceuticals and studying diseases. A new study out of Duke University led by Nenad Bursac, associate professor of biomedical engineering […]
Drugs like Adderall are sometimes being abused as stimulants for people who don’t actually have ADHD, especially by college students. But there’s more to the story. Whether it’s overdiagnoses or people not getting access to drugs that can help them, distribution of drugs has created some interesting trends, especially for young women. The Huffington Post […]
Duke University, and by extension its medical and nursing schools and hospitals, have teamed up with a former NASA worker on a big data system that, seemingly, will allow researchers to analyze “geospatial visualization,” essentially any group of patients with any health issue, in real time. Clinicians and researchers would be able to select, visualize […]
If perception is reality, reality might be about to get quite a bit more intense: Super-senses are no longer just for Peter Parker and Clark Kent. A Duke University study published in Nature Communications shows with a brain implant and some training we may be able to significantly enhance sight, hearing and taste in mammals. Researchers […]
A Duke University spinoff has reached a milestone in tissue engineering as it transplanted the first bioengineered blood vessel into the arm of a patient with end-stage kidney disease. In its first U.S. clinical trial, Humacyte is testing the safety and effectiveness of the blood vessel, which is intended to be an off-the-shelf product that’s […]